Cargando…
Antiviral action of interferon-alpha against porcine transmissible gastroenteritis virus
Swine testis (ST) cell cultures were treated with various doses of recombinant human interferon-alpha 2a (IFN), and assayed for 2′,5′ oligoadenylate synthetase (2–5 A synthetase) activity. Treatment with 100 or 1000 units/ml of IFN resulted in increased 2–5 A synthetase activity, but there was no si...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117519/ https://www.ncbi.nlm.nih.gov/pubmed/7653029 http://dx.doi.org/10.1016/0378-1135(94)00118-G |
_version_ | 1783514389840658432 |
---|---|
author | Jordan, L.T. Derbyshire, J.B. |
author_facet | Jordan, L.T. Derbyshire, J.B. |
author_sort | Jordan, L.T. |
collection | PubMed |
description | Swine testis (ST) cell cultures were treated with various doses of recombinant human interferon-alpha 2a (IFN), and assayed for 2′,5′ oligoadenylate synthetase (2–5 A synthetase) activity. Treatment with 100 or 1000 units/ml of IFN resulted in increased 2–5 A synthetase activity, but there was no significant response to 1 unit/ml of IFN. Titres of porcine transmissible gastroenteritis virus (TGEV) were reduced between 6 and 15 hours post-infection in ST cells treated with 1000 or 2500 units/ml of IFN. Polyacrylamide gel electrophoresis of lysates of TGEV-infected ST cells, and of lysates immunoprecipitated with anti-TGEV antibodies, revealed that the synthesis of the N and S proteins of TGEV was reduced in cells treated with 100 or 1000 units/ml of IFN. Viral RNA production, as determined with a probe which hybridized to the S gene of TGEV, was found to be reduced in ST cells treated with 1000 units/ml of IFN, but not in cells treated with 100 units/ml. It was concluded that, in IFN-treated ST cells, TGEV protein production may be decreased in the absence of reduced viral RNA production, and that 2–5 A synthetase may not be a significant factor in the antiviral activity of IFN against TGEV. |
format | Online Article Text |
id | pubmed-7117519 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1995 |
publisher | Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71175192020-04-02 Antiviral action of interferon-alpha against porcine transmissible gastroenteritis virus Jordan, L.T. Derbyshire, J.B. Vet Microbiol Article Swine testis (ST) cell cultures were treated with various doses of recombinant human interferon-alpha 2a (IFN), and assayed for 2′,5′ oligoadenylate synthetase (2–5 A synthetase) activity. Treatment with 100 or 1000 units/ml of IFN resulted in increased 2–5 A synthetase activity, but there was no significant response to 1 unit/ml of IFN. Titres of porcine transmissible gastroenteritis virus (TGEV) were reduced between 6 and 15 hours post-infection in ST cells treated with 1000 or 2500 units/ml of IFN. Polyacrylamide gel electrophoresis of lysates of TGEV-infected ST cells, and of lysates immunoprecipitated with anti-TGEV antibodies, revealed that the synthesis of the N and S proteins of TGEV was reduced in cells treated with 100 or 1000 units/ml of IFN. Viral RNA production, as determined with a probe which hybridized to the S gene of TGEV, was found to be reduced in ST cells treated with 1000 units/ml of IFN, but not in cells treated with 100 units/ml. It was concluded that, in IFN-treated ST cells, TGEV protein production may be decreased in the absence of reduced viral RNA production, and that 2–5 A synthetase may not be a significant factor in the antiviral activity of IFN against TGEV. Published by Elsevier B.V. 1995-06 2000-03-10 /pmc/articles/PMC7117519/ /pubmed/7653029 http://dx.doi.org/10.1016/0378-1135(94)00118-G Text en Copyright © 1995 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Jordan, L.T. Derbyshire, J.B. Antiviral action of interferon-alpha against porcine transmissible gastroenteritis virus |
title | Antiviral action of interferon-alpha against porcine transmissible gastroenteritis virus |
title_full | Antiviral action of interferon-alpha against porcine transmissible gastroenteritis virus |
title_fullStr | Antiviral action of interferon-alpha against porcine transmissible gastroenteritis virus |
title_full_unstemmed | Antiviral action of interferon-alpha against porcine transmissible gastroenteritis virus |
title_short | Antiviral action of interferon-alpha against porcine transmissible gastroenteritis virus |
title_sort | antiviral action of interferon-alpha against porcine transmissible gastroenteritis virus |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117519/ https://www.ncbi.nlm.nih.gov/pubmed/7653029 http://dx.doi.org/10.1016/0378-1135(94)00118-G |
work_keys_str_mv | AT jordanlt antiviralactionofinterferonalphaagainstporcinetransmissiblegastroenteritisvirus AT derbyshirejb antiviralactionofinterferonalphaagainstporcinetransmissiblegastroenteritisvirus |